Related Experiment Videos
Technique for quantifying the duration of intravenous anesthetic effect
1Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Anesthesiology
|November 1, 1995
Summary
The new mean effect time unifies pharmacokinetics and pharmacodynamics to measure drug effect duration. This metric is more accurate than decrement times, especially for longer infusions, offering better insights into drug recovery.
Area of Science:
- Pharmacology
- Anesthesia
- Pharmacokinetics and Pharmacodynamics
Background:
- Previous studies focused on drug concentration decrease post-infusion, not total drug effect duration.
- Drug effect duration depends on both pharmacokinetic and pharmacodynamic factors.
- A unified measure is needed to assess drug effect duration in binary response scenarios.
Purpose of the Study:
- To introduce a novel method unifying pharmacokinetics and pharmacodynamics.
- To propose a new measure for quantifying drug effect duration.
- To assess the applicability of this measure for drugs used in anesthesia.
Main Methods:
- Proposed 'mean effect time' calculated as the area under the probability of drug effect curve over time.
- Used the logistic (Hill) equation to link drug concentration and effect probability.
- Calculated mean effect times for sufentanil, alfentanil, propofol, and midazolam, comparing them to decrement times.
Main Results:
- Mean effect times exceeded decrement times for midazolam and propofol (steepness parameter delta < 4).
- Mean effect times closely matched decrement times for sufentanil and alfentanil (delta = 6 and 10).
- The difference between mean effect time and decrement time increased with infusion duration; pharmacokinetic variability had minimal impact.
Conclusions:
- Mean effect time offers a valuable concept for understanding drug effect recovery.
- This metric may provide a more comprehensive understanding of drug kinetics than context-sensitive half-times or decrement times.